Secondly, although the association of FOLR3 hypomethylation with NSCLC progression could be deduced, the prognostic values of FOLR3 methylation couldn’t be estimated due to the insufficiency of follow-up data. This evidence concerns the gene FOLR3 and non-small cell lung carcinoma.